AAAAAA

   
Results: 1-9 |
Results: 9
Factor XIII Val34Leu and the risk of myocardial infarction
Authors: Franco, RF Pazin, A Tavella, MH Simoes, MV Marin-Neto, JA Zago, MA
Citation: Rf. Franco et al., Factor XIII Val34Leu and the risk of myocardial infarction, HAEMATOLOG, 85(1), 2000, pp. 67-71
Atypical beta(S) haplotypes are generated by diverse genetic mechanisms
Authors: Zago, MA Silva, WA Dalle, B Gualandro, S Hutz, MH Lapoumeroulie, C Tavella, MH Araujo, AG Krieger, JE Elion, J Krishnamoorthy, R
Citation: Ma. Zago et al., Atypical beta(S) haplotypes are generated by diverse genetic mechanisms, AM J HEMAT, 63(2), 2000, pp. 79-84
Porphyria cutanea tarda in Brazilian patients: Association with hemochromatosis C282Y mutation and hepatitis C virus infection
Authors: Martinelli, ALC Zago, MA Roselino, AMF Filho, AB Villanova, MG Secaf, M Tavella, MH Ramalho, LNZ Zucoloto, S Franco, RF
Citation: Alc. Martinelli et al., Porphyria cutanea tarda in Brazilian patients: Association with hemochromatosis C282Y mutation and hepatitis C virus infection, AM J GASTRO, 95(12), 2000, pp. 3516-3521
Heterogeneous ethnic distribution of the factor V Leiden mutation
Authors: Franco, RF Elion, J Santos, SEB Araujo, AG Tavella, MH Zago, MA
Citation: Rf. Franco et al., Heterogeneous ethnic distribution of the factor V Leiden mutation, GENET MOL B, 22(2), 1999, pp. 143-145
Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis
Authors: Franco, RF Reitsma, PH Lourenco, D Maffei, FH Morelli, V Tavella, MH Araujo, AG Piccinato, CE Zago, MA
Citation: Rf. Franco et al., Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis, THROMB HAEM, 81(5), 1999, pp. 676-679
The prevalence of factor V Arg(306)-> Thr (factor V Cambridge) and factor V Arg(306)-> Gly mutations in different human populations
Authors: Franco, RF Elion, J Tavella, MH Santos, SEB Zago, MA
Citation: Rf. Franco et al., The prevalence of factor V Arg(306)-> Thr (factor V Cambridge) and factor V Arg(306)-> Gly mutations in different human populations, THROMB HAEM, 81(2), 1999, pp. 312-313
A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease
Authors: Franco, RF Morelli, V Lourenco, D Maffei, FH Tavella, MH Piccinato, CE Thomazini, IA Zago, MA
Citation: Rf. Franco et al., A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease, BR J HAEM, 105(2), 1999, pp. 556-559
Are haemochromatosis mutations related to the severity of liver disease inhepatitis C virus infection?
Authors: Martinelli, ALC Franco, RF Villanova, MG Figueiredo, JFC Secaf, M Tavella, MH Ramalho, LNZ Zucoloto, S Zago, MA
Citation: Alc. Martinelli et al., Are haemochromatosis mutations related to the severity of liver disease inhepatitis C virus infection?, ACT HAEMAT, 102(3), 1999, pp. 152-156
Factor VArg(306)-> Thr (factor V Cambridge) and factor V Arg(306)-> Gly mutations in venous thrombotic disease
Authors: Franco, RF Maffei, FH Lourenco, D Morelli, V Thomazini, IA Piccinato, CE Tavella, MH Zago, MA
Citation: Rf. Franco et al., Factor VArg(306)-> Thr (factor V Cambridge) and factor V Arg(306)-> Gly mutations in venous thrombotic disease, BR J HAEM, 103(3), 1998, pp. 888-890
Risultati: 1-9 |